- title: "MaxCyte® Enables a cGMP-Compatible Manufacturing Process for Highly Efficient T Cell Engineering"
  link: https://maxcyte.com/resource/maxcyte-enables-a-cgmp-compatible-manufacturing-process-for-highly-efficient-t-cell-engineering/
  image: assets/images/iStock-1530138291.jpeg
- title: "MaxCyte® Enables Multiplexed NK Cell Engineering"
  link: https://maxcyte.com/resource/maxcyte-enables-multiplexed-nk-cell-engineering/
  image: assets/images/iStock-1383260152.jpeg
- title: "MaxCyte Enables Delivery of Transposons for Highly-Efficient CAR T Cell Engineering"
  link: https://maxcyte.com/resource/delivery-of-transposons-for-highly-efficientcar-t-cell-engineering/
  image: assets/images/iStock-1317697233.jpeg
- title: "MaxCyte® Electroporation Enabled Immunocytokine Development"
  link: https://maxcyte.com/resource/sb-maxcyte-electroporation-enabled-immunocytokine-development/
  image: assets/images/iStock-1384850445.jpeg
- title: "MaxCyte® Enables Development of New, Rapid, Sensitive SARS-CoV-2 Antibody Test"
  link: https://maxcyte.com/resource/maxcyte-enables-development-of-new-rapid-sensitive-sars-cov-2-antibody-test/
  image: assets/images/iStock-1214031771.jpeg
- title: "MaxCyte®: A Versatile Tool for SARS-CoV-2 Response"
  link: https://maxcyte.com/resource/maxcyte-a-versatile-tool-for-sars-cov-2-response/
  image: assets/images/iStock-1441066266.jpeg
- title: "MaxCyte® Enabled Innovative SARS-CoV-2 Vaccine Development"
  link: https://maxcyte.com/resource/maxcyte-enabled-innovative-sars-cov-2-vaccine-development/
  image: assets/images/iStock-1213090148.jpeg
- title: "Off-Target Effects of CRISPR-Cas9 Gene Editing in Human Hematopoietic Stem and Progenitor Cells"
  link: https://maxcyte.com/resource/off-target-effects-of-crispr-cas9-gene-editing-in-human-hematopoietic-stem-and-progenitor-cells/
  image: assets/images/iStock-1398972860.jpeg
